Is Alpha Cognition Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Alpha Cognition Inc (ACOG) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Alpha Cognition Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alpha Cognition Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Alpha Cognition Inc?

Muslim investors may consider investing in Alpha Cognition Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Alpha Cognition Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Alpha Cognition Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Alpha Cognition Inc updated?

The Shariah compliance status of Alpha Cognition Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Alpha Cognition Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Alpha Cognition Inc?

You can check the latest Shariah compliance status of Alpha Cognition Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ACOG Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 02, 2026

Report Source: 2025 Annual Report

Alpha Cognition Inc. Stock Analysis ACOG

United States Health Care Micro Cap Report: 2025 Annual

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The firm's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.

Key Statistics of Alpha Cognition Inc (ACOG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$5.71$6.25

Today's Open

$5.88

Volume

96.13K

P/E Ratio (TTM)

52 Week Range

$4.50$11.54

Market Cap

138.92M

Avg. Volume

43.21K

Dividend Yield

Financial Metrics & Statements of Alpha Cognition Inc (ACOG)

FAQ's for Alpha Cognition Inc (ACOG)

According to Musaffa’s Shariah screening methodology, Alpha Cognition Inc (ACOG) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.